Abstract
ABSTRACT
Background
Financial toxicity threatens the survival and prognosis of cervical cancer patients, yet systematic exploration of its prevalence and full spectrum of protective and risk factors remains limited.
Aims
To investigate the prevalence and factors associated with financial toxicity among patients with cervical cancer.
Design
A cross‐sectional quantitative study.
Methods
We surveyed 351 cervical cancer patients from November 2023 to November 2024 using a general information questionnaire and the patient self‐reported Comprehensive Score for Financial Toxicity. Binary logistic regression identified associated factors.
Results
The 351 participants ranged in age from 25 to 88 years (57.70 ± 11.47 years). The prevalence of financial toxicity was 66.4%. Multivariable analysis demonstrated that each 1‐year increase in age, having commercial insurance and fewer hospitalizations (
Conclusions
This study identified factors associated with financial toxicity in cervical cancer patients, with factors associated including age, commercial insurance, basic medical insurance type, disposable household savings, number of hospitalizations and radiotherapy. These findings may assist healthcare providers in identifying patients at higher risk of financial toxicity and inform the development of individualized care plans.
Implications for the Profession and/or Patient Care
These findings may assist healthcare providers to identify patients who may be at higher risk of financial toxicity early, which may support treatment adherence and health‐related quality of life.
Impact
This study examined financial toxicity prevalence and associated factors among cervical cancer patients, identified key modifiable and non‐modifiable factors for clinical screening, and may inform nursing practice and healthcare policy adjustments.
Reporting Method
This study followed the STROBE guidelines for cross‐sectional studies.
Patient or Public Contribution
No patient or public contribution.